Compare AVTX & DC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVTX | DC |
|---|---|---|
| Founded | 2011 | 2017 |
| Country | United States | United States |
| Employees | 33 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 888.6M | 783.6M |
| IPO Year | 2015 | 2022 |
| Metric | AVTX | DC |
|---|---|---|
| Price | $16.51 | $6.90 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 4 |
| Target Price | ★ $40.57 | $9.48 |
| AVG Volume (30 Days) | 856.9K | ★ 1.2M |
| Earning Date | 05-08-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 72.07 | 27.03 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $27,813,137.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 2312.27 | N/A |
| 52 Week Low | $10.70 | $3.79 |
| 52 Week High | $24.27 | $7.25 |
| Indicator | AVTX | DC |
|---|---|---|
| Relative Strength Index (RSI) | 39.35 | 63.08 |
| Support Level | $15.29 | $5.79 |
| Resistance Level | $16.80 | $6.57 |
| Average True Range (ATR) | 1.00 | 0.26 |
| MACD | -0.20 | 0.01 |
| Stochastic Oscillator | 23.14 | 89.23 |
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
Dakota Gold Corp is a gold exploration and development company focused on revitalizing the Homestake District in Lead, South Dakota. The company holds gold mineral properties surrounding the historic Homestake Mine and is advancing key projects, including the Richmond Hill Project.